Interpreting results from hereditary cancer test by color.com
MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D, SMAD4, STK11, TP53
I'm guessing his prostate cancer might or may not develop some of these mutations (such as the BRCAs), but even if he doesn't develop any of these mutations, he could still develop resistance to his current Zytiga
MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D, SMAD4, STK11, TP53
I'm guessing his prostate cancer might or may not develop some of these mutations (such as the BRCAs), but even if he doesn't develop any of these mutations, he could still develop resistance to his current Zytiga